{"id":"W3013207865","doi":"10.1056/nejmoa1915928","title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1299,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Merck; Bayer","keywords":"Ejection fraction; Heart failure; Cardiology; Fraction (chemistry); Internal medicine; Medicine; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01233707366092977,"score_gpt":0.2460642266950533,"score_spread":0.2337271530341236,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}